Search

Search Constraints

You searched for: Author/Creator Bossi, Ilaria

Search Results

1. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab. Issue 6 (4th March 2015)

2. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab. Issue 6 (4th March 2015)

3. DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan. (22nd June 2015)

5. FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma. (20th June 2014)

6. FOLFOX‐4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma. (20th June 2014)

7. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. Issue 1 (December 2016)